Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA

Nature(2020)10.1038/s41586-020-2835-2Source: DataRank Database

Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA is a research paper published in Nature (2020). On theSindex it has a DataRank of 0. It has been cited 168 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access168 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 6.74)OA: greenTopics (59)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Hanqian Mao,Giulia Fragola ORCID,Jeremy M. Simon ORCID,James L. Krantz,Hannah Bazick ORCID

Live enrichment

PubMed:33087932 OpenAlex:https://openalex.org/W3094331871

NIMH NIH HHS

Grant: R01 MH120125

NIH HHS

Grant: 1R01NS109304-01A1

NICHD NIH HHS

Grant: P50 HD103573

NCI NIH HHS

Grant: P30 CA016086

NINDS NIH HHS

Grant: P30 NS045892

NIMH NIH HHS

Grant: R00 MH102357

NICHD NIH HHS

Grant: U54 HD079124

NICHD NIH HHS

Grant: T32 HD040127

NIMH NIH HHS

Grant: R01 MH118349

NINDS NIH HHS

Grant: R01 NS109304

NINDS NIH HHS

Grant: T32 NS007431

NIMH NIH HHS

Grant: R21 MH085254

FWCI

6.74

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: https://www.springer.com/tdm

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8020672

publisherhttps://www.nature.com/articles/s41586-020-2835-2.pdf

publisherhttps://www.nature.com/articles/s41586-020-2835-2

journalhttps://doi.org/10.1038/s41586-020-2835-2

Fields of Study

CRISPR and Genetic EngineeringGenetic Syndromes and ImprintingRNA modifications and cancerAngelman SyndromeAnimalsCRISPR-Associated Protein 9CRISPR-Cas SystemsDependovirusDisease Models, AnimalFemaleGene EditingGene SilencingGenetic TherapyGenetic VectorsHumansMaleMiceMice, Inbred C57BLNervous SystemPaternal InheritancePhenotypeRNA, Long NoncodingUbiquitin-Protein Ligases

MeSH Terms

Gene EditingPaternal InheritanceCRISPR-Associated Protein 9DependovirusAnimalsDisease Models, AnimalFemaleGenetic VectorsHumansMaleMice, Inbred C57BLNervous SystemPhenotypeGenetic TherapyAngelman SyndromeRNA, Guide, KinetoplastidaGene SilencingUbiquitin-Protein LigasesMiceRNA, Long NoncodingCRISPR-Cas Systems

Keywords

UBE3AAngelman syndromeBiologyGeneticsNeurodevelopmental disorderCas9Adeno-associated virusGenomic imprintingCRISPRAlleleRNAPhenotypeGeneVector (molecular biology)Gene expression

Sustainable Development Goals

SDG 0: Good health and well-being